tiprankstipranks
Trending News
More News >
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Hong Kong Market
Advertisement

Tianda Pharmaceuticals Ltd. (0455) Price & Analysis

Compare
0 Followers

0455 Stock Chart & Stats


Financials

0455 FAQ

What was Tianda Pharmaceuticals Ltd.’s price range in the past 12 months?
Tianda Pharmaceuticals Ltd. lowest stock price was HK$0.07 and its highest was HK$0.27 in the past 12 months.
    What is Tianda Pharmaceuticals Ltd.’s market cap?
    Tianda Pharmaceuticals Ltd.’s market cap is HK$374.11M.
      When is Tianda Pharmaceuticals Ltd.’s upcoming earnings report date?
      Tianda Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 28, 2025 which is in 132 days.
        How were Tianda Pharmaceuticals Ltd.’s earnings last quarter?
        Tianda Pharmaceuticals Ltd. released its earnings results on Mar 28, 2025. The company reported -HK$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.016.
          Is Tianda Pharmaceuticals Ltd. overvalued?
          According to Wall Street analysts Tianda Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Tianda Pharmaceuticals Ltd. pay dividends?
            Tianda Pharmaceuticals Ltd. pays a Annually dividend of HK$0.002 which represents an annual dividend yield of 2.99%. See more information on Tianda Pharmaceuticals Ltd. dividends here
              What is Tianda Pharmaceuticals Ltd.’s EPS estimate?
              Tianda Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Tianda Pharmaceuticals Ltd. have?
              Tianda Pharmaceuticals Ltd. has 2,150,041,700 shares outstanding.
                What happened to Tianda Pharmaceuticals Ltd.’s price movement after its last earnings report?
                Tianda Pharmaceuticals Ltd. reported an EPS of -HK$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Tianda Pharmaceuticals Ltd.?
                  Currently, no hedge funds are holding shares in HK:0455

                  Company Description

                  Tianda Pharmaceuticals Ltd.

                  Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Wai Yuen Tong Medicine Holdings Limited
                  China NT Pharma Group Co., Ltd.
                  Fusen Pharmaceutical Co., Ltd.
                  Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H
                  Huakang Biomedical Holdings Company Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis